Results 31 to 40 of about 698,293 (229)

The effect of weight loss on HDL subfractions and LCAT activity in two genotypes of APOA-II -265T>C polymorphism

Nutrition Journal, 2017
Background People may have different responses to the same environmental changes. It has been reported that genome variations may be responsible for these differences. Also, HDL subfractions may be influenced by different genetic variations.
Masoumeh Moradi, Maryam Mahmoudi, Ahmad Saedisomeolia, Roxana Zahirihashemi, Fariba Koohdani   +4 more
doaj   +1 more source

Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease[S]

Journal of Lipid Research, 2010
Animal experiments show that the kidney contributes to apolipoprotein (apo)A-I catabolism. We tested relationships of HDL cholesterol (HDL-C) and apo-I with kidney function in subjects without severe chronic kidney disease.
Jan A. Krikken, Ron T. Gansevoort, Robin P.F. Dullaart   +2 more
doaj   +1 more source

Stimulation of lecithin: cholesterol acyltransferase activity by apolipoprotein A‐II in the presence of apolipoprotein A‐I [PDF]

European Journal of Biochemistry, 1986
Various combinations of incorporation and addition of apolipoprotein A‐I (apo A‐I) and apolipoprotein A‐II (apo A‐II) individually or together to a defined lecithin‐cholesterol (250/12.5 molar ratio) liposome prepared by the cholate dialysis procedure were used to study the effect of apo A‐II on lecithin: cholesterol acyltransferase (LCAT, EC 2.3.1.43)
C H, Chen, J J, Albers
openaire   +2 more sources

Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential

FEBS Letters, EarlyView.
Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta, Hari Baskar Balasubramanian, Amir Pasokh, Marietta Zille   +3 more
wiley   +1 more source

Differential tissue-specific expression of human apoA-I and apoA-II

Journal of Lipid Research, 1991
To evaluate the sources of high density lipoprotein (HDL) particles containing only apolipoprotein A-I (apoA-I), the synthesis of apoA-I and apolipoprotein A-II (apoA-II) was examined in human liver and small intestine as well as the human intestinally ...
TL Eggerman, JM Hoeg, MS Meng, A Tombragel, D Bojanovski, HB Brewer, Jr   +5 more
doaj   +1 more source

Apolipoprotein A-II regulates HDL stability and affects hepatic lipase association and activity Published, JLR Papers in Press, February 16, 2004. DOI 10.1194/jlr.M300431-JLR200

Journal of Lipid Research, 2004
The effect of apolipoprotein A-II (apoA-II) on the structure and stability of HDL has been investigated in reconstituted HDL particles. Purified human apoA-II was incorporated into sonicated, spherical LpA-I particles containing apoA-I, phospholipids ...
Jonathan G. Boucher, T. Ramsamy, S. Braschi, D. Sahoo, T. Neville, D. Sparks   +5 more
semanticscholar   +1 more source

Cyclic azapeptide CD36 ligand attenuates cardiac injury and reduces long‐chain fatty acid accumulation after myocardial ischemia–reperfusion in mice

FEBS Open Bio, EarlyView.
In a murine model of myocardial ischemia and reperfusion (MI/R), the CD36 azapeptide ligand MPE‐298 reduces cardiac injury and transiently lowers left ventricular long‐chain fatty acids (LCFAs) accumulation 3 h after reperfusion, accompanied by a decrease of oxidative stress and inflammation‐associated genes' expression in the heart and adipose tissue.
Jade Gauvin, Naghme Radmannia, David N. Huynh, Liliane Ménard, Caroline Daneault, Maïté Veilleux, Ahsanullah Ahsanullah, André C. Carpentier, William D. Lubell, Matthieu Ruiz, Huy Ong, Sylvie Marleau, Simon‐Pierre Gravel   +12 more
wiley   +1 more source

The prognostic significance of HDL-associated apolipoproteins in ascitic fluid from patients with cirrhosis and spontaneous bacterial peritonitis

Scientific Reports
Apolipoproteins (Apo) A-I and A-II are major components of high-density lipoproteins (HDL) with immunomodulatory functions. Low serum apoA-I levels indicate complications of cirrhosis. We hypothesized that HDL-associated apolipoproteins in ascitic fluid (
Mohamad Murad, Philipp A. Reuken, Kristin Schubert, Johanna Reißing, Oluwatomi Ibidapo-Obe, Karsten Große, Mick Frissen, Frederic Haedge, Majda El-Hassani, Martin von Bergen, Tony Bruns   +10 more
doaj   +1 more source

Apolipoprotein gene expression in the rabbit: abundance, size, and distribution of apolipoprotein mRNA species in different tissues

Journal of Lipid Research, 1988
We have used human apolipoprotein cDNAs as hybridization probes to study the relative abundance and distribution of apolipoprotein mRNAs in rabbit tissues by RNA blotting analysis.
C Lenich, P Brecher, S Makrides, A Chobanian, V I Zannis   +4 more
doaj   +1 more source

Apolipoprotein A-II [PDF]

Arteriosclerosis, Thrombosis, and Vascular Biology, 2013
Apolipoprotein (apo) A-II is the second most abundant protein on high-density lipoprotein (HDL), accounting for ≈20% of total HDL protein.1 Like apo A-I, the most abundant HDL protein, it contains a tandem array of amphipathic helices. It is considered an exchangeable apolipoprotein because it can dissociate from lipoproteins, although it has greater ...
openaire   +2 more sources